-
Most Recent
Cannabis Stocks
Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.
3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030
These are the cannabis stocks to buy as they represent companies with improving fundamentals and accelerated growth outlook.
7 Growth Stocks That Could 7X in the Next 7 Years
Investors consider these growth stocks to buy since they represent companies with good fundamentals and a positive industry outlook.
3 Cannabis Stocks to Sell in August Before They Crash & Burn
Marijuana could be a major industry in the U.S. if it was legalized but these cannabis stocks to sell have other problems to contend with.
Other industries you might be interested in
Recent Cannabis Stocks Articles
Why Canopy Growth Stock is a Buy Today as Cannabis’ Bad Year Nears End
It’s unlikely to be the next Netflix or Microsoft, but Canopy Growth stock has made the case for today’s investors to take a nibble
Pair-Trading Cannabis Stocks: Go Long THC and Short CBD
Cannabis stocks have taken a huge hit in 2019 and will likely remain volatile while the industry goes through its growing pains. Long-term cannabis bulls can consider mitigating their portfolio risk by going long top legal cannabis producers and short CBD-focused stocks.
The Clock Is Ticking for Aurora Cannabis After a Tough Year
Aurora Cannabis hopes that CBD oil and converting debt to equity can save it from the scrap heap.
It Doesn’t Look as If 2020 Will Be Any Better for Hexo Stock
Cash burn will result in equity dilution. Slower growth likely in medicinal and recreational cannabis due to regulatory headwinds.
A Close Look Shows New Age Beverages Stock Remains a Sell
NBEV stock is intriguing as its revenue is growing and it has a CBD opportunity. But NBEV is failing to deliver on its promise.
Canopy Growth Is Halfway to a Full Blown Recovery
Investors who are looking for marijuana stocks should have CGC on their radar as it looks like the best of the bunch right now.
Aurora Cannabis Will Survive, But It’s Still a Poor Investment
Aurora Cannabis isn't going to go bankrupt soon, so don't worry about that. But those fears show just how far it has fallen.
Canopy Growth Stock Rally Should Offer Many Trading Opportunities
There are profits in trading Canopy Growth stock as the sector finds its footing on Wall Street. CGC is in a rebound effort from earnings.
Why There’s No Rush to Buy Tilray Stock Anytime Soon
TLRY stock is down big since the passage of the MORE Act, and that's a sign of more troubles to come for Tilray stock.
With a Cloudy Future and Shaky Financials, NBEV Stock Is a Falling Knife
At this point NBEV stock looks like a falling knife with very little upside potential.
Canopy Growth Stock Popped — What’s Going On?
Canopy Growth stock has enjoyed a rare week of good news. But investors should hold off on buying CGC stock for now.
Canopy Growth Needs You to Call the Cops
Canopy Growth hopes that infusing chocolate with THC will deliver high sales that legal bud hasn't under new CEO David Klein.
Can Cronos Stock Break Out of Its Downtrend?
Cronos stock is surviving thanks to its large cash balance. However, can CRON stock finally turn the corner and snap out of its funk?
Patience With Aurora Cannabis Will Pay Off in 2020
Presently depressed Canadian consumer cannabis demand trends could reverse in 2020. If they do, Aurora Cannabis could rebound in a big way.
Consider Aphria Stock as the Cannabisphere Burns
But does this make APHA stock a buy today? Perhaps. Analyst consensus projects positive earnings-per-share for Aphria stock in 2020 and 2021. Meanwhile, the above-mentioned peers will remain unprofitable. The bigger names dominate the headlines. But under-the-radar Aphria may be the best "pot stock" buy.
Why Investors Should Continue to Say No to Hexo Stock
At the end of the day, the cannabis industry will birth only 5 to 10 big winners, and HEXO stock likely won't be one of them.
Dilution, Not Bankruptcy, Is the Key Risk Facing Aurora Cannabis Stock
Aurora stock continues to fall, and its risk seems to be accelerating. But the imminent risk is more issuance of ACB stock, not bankruptcy.
Expect More Dilution, Debt, Deficits, and a Deep Drop in ACB Stock
Expect more dilution, debt, deficits, and a deep drop in Aurora stock. Aurora Cannabis free cash flow losses will require more debt and dilution.
